Bio-rad Laboratories, Inc. (BIO) earnings: date, estimates and history
Price $366.36 · data as of November 13, 2026
Next earnings report
The date appears here once Bio-rad Laboratories confirms it, usually two to four weeks before the report.
Track record
Bio-rad Laboratories beat the consensus earnings estimate in 3 of its last 4 reports, by +20.4% on average. On report days the stock moved 5.0% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 4, 2026 Sep/2026 | $2.23 | $2.65 | +19.1% | $656M | +0.5% | −1.6% |
| August 4, 2026 Jun/2026 | $1.75 | $2.62 | +50.1% | $651M | −0.1% | +3.9% |
| April 30, 2026 Mar/2026 | $1.99 | $1.89 | −4.8% | $592M | +1.1% | −6.8% |
| October 29, 2025 Sep/2025 | $1.93 | $2.26 | +17.0% | $653M | +0.5% | −7.8% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Bio-rad Laboratories’s next earnings date?
Bio-rad Laboratories has not confirmed its next report date yet. Its last report was on November 4, 2026.
Did Bio-rad Laboratories beat earnings last quarter?
Yes, it reported EPS of $2.65 on November 4, 2026 against an estimate of $2.23 (a +19.1% surprise), and the stock moved −1.6% the next trading day.
What EPS do analysts expect next quarter?
The consensus estimate is $2.83 per share on revenue of about $689M.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar